Skip to content
You can now search across every topic, entity and event.What's new
UK Startups and Innovation
13APR

London VC hits £2.14bn, Nscale takes 70%

2 min read
17:59UTC

March 2026 was a headline month for London startup funding. Strip out one mega-round and the picture looks different: 44 deals shared £644m.

TechnologyDeveloping
Key takeaway

Strip out one deal and London's £2.14bn VC month becomes a £644m one across 44 rounds.

London startups raised £2.14bn across 45 deals in March 2026, up 21% year-on-year 1. Six late-stage deals captured £1.88bn, or 87.7% of the month's total. Nscale alone accounted for roughly £1.5bn, approximately 70% of everything raised. Excluding Nscale, the remaining 44 deals raised £644m.

AI companies took 88% of capital across 22 of 45 deals, but two-thirds of that AI allocation was a single cheque. At the early stage, 28 deals raised £106m total, with a median deal size of £1.9m. That is healthy deal volume but modest scale.

The distribution tells the story more clearly than the headline. UK AI funding is bifurcated: a handful of mega-rounds at the top, a large field of small rounds at the bottom, and very little in between. A seed-stage founder raising £2m is operating in a different capital market from a growth-stage company raising £200m. The headline number of £2.14bn creates an impression of abundance that the median founder does not experience.

Deep Analysis

In plain English

London tech companies raised £2.14bn from investors in March 2026, which sounds like a lot. But one company, Nscale, accounted for £1.5bn of that on its own. Remove Nscale from the total, and the remaining 44 companies raised £644m between them. For small, early-stage companies, 28 deals were done at an average of about £3.8m each. That is the part of the market that matters most for founders just starting out, and those numbers look stable rather than exceptional.

What could happen next?
  • Consequence

    Headline UK VC figures in 2026 will be systematically inflated by AI mega-rounds, making it difficult to assess underlying early-stage ecosystem health without normalising for outliers.

First Reported In

Update #1 · State capital floods in, seed money drains

London TechWatch· 13 Apr 2026
Read original
Different Perspectives
Institute of Physics
Institute of Physics
The Institute has long argued STFC's national-laboratory infrastructure, not its grant programmes, is the binding constraint on UK physics output, and warns mothballing capacity like Clara removes capability that cannot be rebuilt on a four-year cycle. It represents the discovery-science community absorbing the reallocation the Bank's equity cheques do not touch.
Helsing
Helsing
The Munich-headquartered defence-AI firm chose Plymouth over Continental sites for a £350m manufacturing plant building underwater surveillance gliders, alongside its record raise. Its choice of postcode signals confidence in UK manufacturing capacity for defence hardware even as it looks abroad for the capital financing that hardware.
Dragoneer Investment Group, Lightspeed Venture Partners and Iconiq
Dragoneer Investment Group, Lightspeed Venture Partners and Iconiq
The three US growth-capital firms backed Helsing's $1.8bn round at an $18bn valuation, more than doubling the mark set only a year earlier, with demand reportedly exceeding the capital on offer. Their money, not a UK sovereign vehicle, is what funds the Plymouth plant, extending a pattern of foreign capital underwriting British defence-hardware manufacturing this cycle.
British Business Bank
British Business Bank
The Bank wrote its largest-ever direct life-sciences cheque into Alchemab and added a £6.5bn SME lending guarantee the same week UKRI confirmed the STFC cuts. It is deploying an April mandate change letting it lead venture rounds and invest directly up to £60m per company, treating equity extension rounds and small-business debt as newly within its risk appetite.
Daphni
Daphni
The Paris seed fund joined Speedinvest and three UK backers in Astral Systems' GBP23m Series A for modular fusion reactors, one of the round's five European co-investors betting on lab-to-market fusion ahead of any working commercial reactor. Unlike CuspAI's all-foreign cap table, this round kept a UK lead investor in Mercia Ventures.
EQT
EQT
EQT, appointed by the European Innovation Council to run the EUR5bn Scaleup Europe Fund, entered advanced talks for a further CuspAI stake reported on 3 July, the fund's first pursuit of a UK-founded winner. A closed deal would put EU sovereign capital, not a UK vehicle, on the cap table of a company Britain's own funds passed over.